Clinical trials
Recruiting Phase 1 Multiple Myeloma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
106 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 2 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 9 |
| 2023 | 10 |
| 2024 | 27 |
| 2025 | 25 |
| 2026 | 23 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 106 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Washington University School of Medicine | 4 |
| Zhejiang University | 4 |
| AbbVie | 3 |
| Genentech, Inc. | 3 |
| Oncotherapeutics | 3 |
| Peking University First Hospital | 3 |
| Beijing GoBroad Hospital | 2 |
| Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2 |
| Chongqing Precision Biotech Co., Ltd | 2 |
| Chunrui Li | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 106 |
| Recurrence | 18 |
| Hematologic Neoplasms | 6 |
| Leukemia, Plasma Cell | 6 |
| Lymphoma, Non-Hodgkin | 6 |
| Leukemia, Myeloid, Acute | 5 |
| Lymphoma, B-Cell | 5 |
| Neoplasms | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Lymphoma | 3 |
Trials
Showing 1 to 25 of 106. Each trial links to its page on Pharma Observatory.
6 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.